InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Rangwala Reshma, Vice-Présidente Exécutive et Directrice Médicale. Director active across 1 companies, notably Karyopharm Therapeutics Inc.. Cumulatively, 3 filings have been recorded. The latest transaction was disclosed on 13 May 2026 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations3 total
0947 shares0
Common Stock
SEC:0001193125-26-226685·
0947 shares0
Common Stock
SEC:0001193125-26-226685:0·
065,000 shares0
Common Stock
SEC:0001209191-22-026425:0·
3 of 3 declarations
About Rangwala Reshma
Reshma Rangwala is the EVP & Chief Medical Officer at Karyopharm Therapeutics Inc. She oversees the company's medical and scientific initiatives, ensuring that research and development meet the highest standards. Her expertise is crucial for the success of the company's therapeutic programs.
